End-of-day quote
NORDIC GROWTH MARKET
03:30:00 01/07/2024 am IST
|
5-day change
|
1st Jan Change
|
7.1
SEK
|
-1.39%
|
|
-3.40%
|
+42.00%
|
Fiscal Period: June |
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
85.23
|
67.88
|
82.19
|
83.71
|
Enterprise Value (EV)
1 |
64.72
|
53.26
|
74.82
|
77.22
|
P/E ratio
|
-15.6
x
|
-17.2
x
|
-11.3
x
|
-12.2
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
26,26,33,493
x
|
60,02,56,710
x
|
EV / Revenue
|
-
|
-
|
23,90,89,567
x
|
55,36,98,961
x
|
EV / EBITDA
|
-13.1
x
|
-13.5
x
|
-10.4
x
|
-11.3
x
|
EV / FCF
|
-2,13,72,769
x
|
-1,15,80,653
x
|
-1,57,82,997
x
|
5,14,60,325
x
|
FCF Yield
|
-0%
|
-0%
|
-0%
|
0%
|
Price to Book
|
4.25
x
|
4.16
x
|
8.87
x
|
32.5
x
|
Nbr of stocks (in thousands)
|
15,220
|
15,220
|
15,220
|
15,220
|
Reference price
2 |
5.600
|
4.460
|
5.400
|
5.500
|
Announcement Date
|
19/11/20
|
18/11/21
|
25/11/22
|
24/11/23
|
Fiscal Period: June |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
|
-
|
-
|
-
|
0.3129
|
0.1395
|
EBITDA
1 |
-3.339
|
-4.922
|
-3.957
|
-7.201
|
-6.807
|
EBIT
1 |
-3.341
|
-4.934
|
-3.964
|
-7.207
|
-6.811
|
Operating Margin
|
-
|
-
|
-
|
-2,302.98%
|
-4,884.2%
|
Earnings before Tax (EBT)
1 |
-3.35
|
-4.942
|
-3.967
|
-7.236
|
-6.895
|
Net income
1 |
-3.633
|
-4.962
|
-3.982
|
-7.239
|
-6.901
|
Net margin
|
-
|
-
|
-
|
-2,313.25%
|
-4,948.58%
|
EPS
2 |
-0.2900
|
-0.3600
|
-0.2600
|
-0.4800
|
-0.4500
|
Free Cash Flow
|
-
|
-3.028
|
-4.599
|
-4.741
|
1.501
|
FCF margin
|
-
|
-
|
-
|
-1,514.86%
|
1,075.97%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
19/11/20
|
19/11/20
|
18/11/21
|
25/11/22
|
24/11/23
|
Fiscal Period: June |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
4.42
|
20.5
|
14.6
|
7.37
|
6.49
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-3.03
|
-4.6
|
-4.74
|
1.5
|
ROE (net income / shareholders' equity)
|
-
|
-41.1%
|
-21.9%
|
-56.6%
|
-117%
|
ROA (Net income/ Total Assets)
|
-
|
-24.3%
|
-13.1%
|
-32.9%
|
-45.6%
|
Assets
1 |
-
|
20.38
|
30.33
|
22
|
15.14
|
Book Value Per Share
2 |
0.3200
|
1.320
|
1.070
|
0.6100
|
0.1700
|
Cash Flow per Share
2 |
0.3500
|
1.350
|
0.9600
|
0.4800
|
0.4300
|
Capex
1 |
0.01
|
0.02
|
-
|
0
|
-
|
Capex / Sales
|
-
|
-
|
-
|
1.31%
|
-
|
Announcement Date
|
19/11/20
|
19/11/20
|
18/11/21
|
25/11/22
|
24/11/23
|
|
1st Jan change
|
Capi.
|
---|
| +42.00% | 10.16M | | +54.20% | 823B | | +42.31% | 641B | | -6.62% | 352B | | +16.91% | 324B | | +8.10% | 301B | | +14.00% | 241B | | +1.64% | 223B | | +13.66% | 218B | | +7.72% | 167B |
Other Pharmaceuticals
|